|
|
Gene Symbol |
HLA-DRB1 |
|
Aliases |
DRB1, HLA-DR1B, HLA-DRB, SS1 |
|
Entrez Gene ID |
|
|
Gene Name |
Major histocompatibility complex, class II, DR beta 1 |
|
Chromosomal Location |
6p21.32 |
|
HGNC ID |
|
|
Summary |
HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa. It is encoded by 6 exons. Exon one encodes the leader peptide; exons 2 and 3 encode the two extracellular domains; exon 4 encodes the transmembrane domain; and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and some alleles have increased frequencies associated with certain diseases. There are multiple pseudogenes of this gene. [provided by RefSeq, Feb 2020]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Major histocompatibility complex, class II, DR beta 1, major histocompatibility complex, class II, DR beta 1 precursor, HLA class II histocompatibility antigen, DR-1 beta chain, MHC class II HLA-DR beta 1 chain, human leucocyte antigen DRB1, lymphocyte antigen DRB1 |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
|
P04439 |
P04439 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Digestive System Diseases |
Liver Diseases |
|
Colitis |
|
Hepatitis |
|
Pancreatitis |
|
Crohn Disease |
|
Enteritis |
|
Ear Or Mastoid Diseases |
Meniere Disease |
|
Endocrine System Diseases |
Ketosis-prone diabetes |
|
Brittle diabetes |
|
Diabetes Mellitus |
|
PCOS |
|
Immune System Diseases |
Sarcoidosis |
|
Rheumatoid Arthritis |
|
Glomerulonephritis |
|
Autoimmune Diabetes |
|
Urticaria |
|
Lupus Erythematosus |
|
Libman-Sacks Disease |
|
Neoplasms |
Lymphoma |
|
Multiple Sclerosis |
|
Oropharyngeal Cancer |
|
Reticulosarcoma |
|
Vulvar Cancer |
|
Nervous System Diseases |
Eosinophilia-Myalgia Syndrome |
|
Cerebrovascular Disorders |
|
Psychiatric/Brain disorders |
Autistic Disorder |
|
Narcolepsy |
|
Schizophrenia |
|
Bipolar Disorder |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Nephrotic Syndrome |
|
Reproductive disorders |
Preeclampsia |
|
Respiratory Tract Diseases |
Asthma |
|
Beryllium Disease |
|
|
References |
|
|
Kaibe Mamiko, Takakuwa Koichi, Murakawa Haruo, Ishii Keisuke, Tamura Masaki, Tanaka Kenichi |
Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan. |
Am J Reprod Immunol. 2006 Apr;55(4):301-6. doi: 10.1111/j.1600-0897.2006.00369.x. |
Abstract
PROBLEM: The objective of this study was to identify the human leukocyte antigen (HLA) alleles that confer susceptibility or resistance to polycystic ovary syndrome (PCOS) in the Japanese population. METHOD OF STUDY: HLA-A, -B and -C antigens were determined in 56 patients with PCOS using conventional serological method. HLA-DRB1 genotypes were determined using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 68 patients with PCOS. As a control population, 237 healthy individuals (males and females) were examined concerning HLA-A, -B and -C antigens, and 292 individuals were examined concerning HLA-DRB1 genotypes. The rate of possession of each antigen was compared between the two populations. RESULTS: The rate of possession of the HLA-A11 and HLA-DRB1*0403 in the patients with PCOS was significantly higher compared with that in the control group. The rate of possession of HLA-B39 in the patients with PCOS was significantly lower compared with that in the general population group. CONCLUSION: Human leukocyte antigen systems appear to be linked to PCOS. |
|
|
|